Unlocking the Future of Stem Cell Transplants: New Advances in Hematopoietic Cell Therapies
In the video below, Dr. Michael Grunwald discusses the transformative potential of hematopoietic cell transplantation, also known as stem cell or bone marrow transplantation, particularly for patients with myeloproliferative neoplasms (MPNs). This advanced treatment, though not necessary for all MPN patients, offers a beacon of hope for a select group, leveraging the body’s immune system […]
Innovative Approach to Improve Quality of Life Post-Stem Cell Transplantation
A recent study published in the June 2024 issue of JNCCN—Journal of the National Comprehensive Cancer Network highlights a promising new approach for alleviating anxiety and enhancing the quality of life in patients undergoing hematopoietic stem cell transplantation (HSCT). This pilot study, conducted by researchers at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, explored […]
Stem Cell-Based Therapies for Lymphoma
Understanding Lymphoma and the Promise of Stem Cell Therapy Lymphoma, a type of blood cancer that affects the lymphatic system, presents a significant health challenge worldwide. It’s a complex disease with various subtypes, each requiring a unique approach to treatment. In recent years, stem cell therapy has emerged as a beacon of hope for many […]
Factors to Consider When Selecting Mismatched Unrelated Donors for Stem Cell Transplantation
In a recent interview at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX, Dr. Rohtesh Mehta from the Fred Hutchinson Cancer Research Center in Seattle, WA, discussed the crucial factors to consider when selecting mismatched unrelated donors (MMUDs) for stem cell transplantation (SCT). Historically, there were limited […]
Innovative Cell Therapy, Omisirge, Receives FDA Approval to Reduce Infection Risk in Blood Cancer Treatments
The FDA has approved Omisirge (omidubicel-onlv), a modified allogeneic cord blood-based cell therapy designed to speed up the recovery of neutrophils and reduce infection risk. Omisirge is intended for use in adults and pediatric patients aged 12 and older with blood cancers who are undergoing umbilical cord blood transplantation after a myeloablative conditioning regimen. Blood […]
Boosting Stem Cell Harvest: A Promising Combo Therapy Revolutionizes Transplant Success
A recent study published in the European Pharmaceutical Review has revealed that a combination therapy can significantly improve the collection of stem cells from donors. The therapy utilizes Plerixafor, a CXCR4 antagonist, in conjunction with granulocyte-colony stimulating factor (G-CSF), which helps mobilize stem cells from bone marrow to peripheral blood. The study found that this […]
Jasper Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium
REDWOOD CITY, Calif., June 23, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with stem cell therapies, today announced that the Company will participate at the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 28, 2022. Ronald Martell, Chief Executive Officer, Jeet Mahal, Chief Operating & […]
ExCellThera announces new publication showing its ECT-001 cell therapy improves transplant access for all patients
MONTREAL, April 13, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company delivering molecules and bioengineering solutions to expand and engineer various cell lines for use in next generation cell and gene therapies, announced today the publication of a scientific article entitled “UM171 expansion of cord blood improves donor availability and HLA […]